Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

AUB Group (AUB AU) Opens Books To EQT's NBIO

Iress (IRE AU) Accepts EQT's Latest Proposal

Quiddity Advisors

Event-Driven

<ul>
<li>On the 28th October 2025, <strong><a href="https://www.smartkarma.com/entities/aub-group-limited" target="_blank" data-smartkarma-citation="entities:11179:1" rel="noopener">AUB Group Limited (AUB AU)</a></strong>, an insurance "matchmaker", announced a NBIO, via a Scheme, from EQT at A$45/share, a ~40% premium to undisturbed.</li>
<li>The share price has consistently traded wide to terms, not just because of the transactions' indicative nature; but EQT's track record on progressing from indicative to firm is not optimum.</li>
<li>This morning AUB announced CVC was teaming up with EQT, at $45/share; and concurrently requested additional due diligence. This has been granted by AUB. </li>
</ul>


On the 28th October 2025, AUB Group Limited (AUB AU), an insurance "matchmaker", announced a NBIO, via a Scheme, from EQT at A$45/share, a ~40% premium to undisturbed.
The share price has consistently traded wide to terms, not just because of the transactions' indicative nature; but EQT's track record on progressing from indicative to firm is not optimum.
This morning AUB announced CVC was teaming up with EQT, at $45/share; and concurrently requested additional due diligence. This has been granted by AUB. 


CVC Joins EQT In Pursuit Of AUB Group (AUB AU)